Data / Drug companies / Supriya Lifescience Limited
Supriya Lifescience Limited: 31 products in the FDA NDC directory, labeler code 61281
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Supriya Lifescience Limited (labeler code 61281) lists 31 products in the FDA National Drug Code Directory. By type: 31 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 30, 2024.
The request: Watch Supriya Lifescience Limited (FDA labeler code 61281): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 61281
- Products in commercial distribution
- 31
- Packages
- 117
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 2, Schedule IV 3
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 21, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 31 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 31 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 31 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Midazolam | 61281-1100 | Powder | Bulk ingredients | December 30, 2024 |
| Midazolam hcl | 61281-1050 | Powder | Bulk ingredients | December 30, 2024 |
| Semaglutide | 61281-8700 | Powder | Bulk ingredients | September 25, 2024 |
| Dexmedetomidine hcl | 61281-9800 | Powder | Bulk ingredients | December 1, 2023 |
| Allopurinol | 61281-9750 | Powder | Bulk ingredients | July 31, 2023 |
| Aspirin | 61281-7250 | Powder | Bulk ingredients | August 18, 2022 |
| Bisoprolol fumarate | 61281-5250 | Powder | Bulk ingredients | July 28, 2022 |
| Albuterol sulfate | 61281-3700 | Powder | Bulk ingredients | March 15, 2019 |
| Hydroxocobalamin hydrochloride | 61281-9651 | Powder | Bulk ingredients | March 13, 2019 |
| Colchicine | 61281-3600 | Powder | Bulk ingredients | November 26, 2018 |
| Cetirizine hydrochloride | 61281-4250 | Powder | Bulk ingredients | August 18, 2017 |
| Hydroxocobalamin acetate | 61281-9700 | Powder | Bulk ingredients | February 24, 2017 |
| Hydroxocobalamin | 61281-9600 | Powder | Bulk ingredients | February 24, 2017 |
| Dextromethorphan hydrobromide | 61281-6500 | Powder | Bulk ingredients | January 31, 2017 |
| Pentoxifylline | 61281-3500 | Powder | Bulk ingredients | November 2, 2016 |
| Esketamine hydrochloride | 61281-8300 | Powder | Bulk ingredients | June 15, 2015 |
| Sildenafil citrate | 61281-1500 | Powder | Bulk ingredients | April 10, 2014 |
| Tramadol hydrochloride | 61281-8500 | Powder | Bulk ingredients | March 18, 2014 |
| Riboflavin 5 phosphate sodium | 61281-7000 | Powder | Bulk ingredients | November 21, 2013 |
| Diphenhydramine hydrochloride | 61281-6000 | Powder | Bulk ingredients | November 21, 2013 |
| Pheniramine maleate | 61281-5000 | Powder | Bulk ingredients | November 21, 2013 |
| Dexchlorpheniramine maleate | 61281-3400 | Powder | Bulk ingredients | November 21, 2013 |
| Pyrilamine maleate | 61281-1000 | Powder | Bulk ingredients | November 21, 2013 |
| Chlorpheniramine maleate | 61281-3300 | Powder | Bulk ingredients | November 20, 2013 |
| Dexbrompheniramine maleate | 61281-4000 | Powder | Bulk ingredients | November 6, 2013 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.